Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • GPU vs Phi: advice needed

    A while ago I asked a general question about practical usability of GPU- and Phi- based platforms for multithread-enabled bioinformatics applications. I am aware of previously held discussion here. My understanding that there was not much experience accumulated yet with use of these systems to outline the differences in capabilities. I wonder if there is more of such experience now. Basically I have choice to obtain a RHEL 6 server equipped with 2 8-core Xeon E5 2690 and 4 either K20x GPU or 60-core Xeon Phi coprocessors. The price is about the same. Microway engineers advise to go with GPU as there are more applications developed.
    As I am not programmer, rather a self-educating end user, my question is which configuration will be more usable in the current universe of bioinformatis applications without code modifications? Please forgive if my questions sound naive. For example, very likely I will not be able to take advantage of thousands of cores with the GPU configuration when using GNU parallel or multithreading in BWA or blast+ without significant investment in code modification. But what about Phi - can I take immediate advantage of 240 cores with the Phi configuration?

  • #2
    We had a recent discussion on this with input from Rick Westerman: http://seqanswers.com/forums/showthread.php?t=20931

    I/O and memory needs of most NGS applications make use of either the GPU/Phi impractical at this time. Unless you have a use case identified for either the GPU/Phi, you may be better off putting that money towards upgrade of some other components.
    Last edited by GenoMax; 09-11-2013, 06:47 AM.

    Comment


    • #3
      While GPU-based NGS applications are not that many, Phi-based NGS applications are basically nil (Let me know if you know of one). soap3-dp is a GPU-based application that you can use to replace bwa.

      I think you will only pick Phi if you have some floating point application that is based on some old code optimized for x86. There aren't many such application for NGS. Therefore it makes no sense to use Phi at all.

      Comment


      • #4
        Originally posted by GenoMax View Post
        We had a recent discussion on this with input from Rick Westerman: http://seqanswers.com/forums/showthread.php?t=20931

        I/O and memory needs of most NGS applications make use of either the GPU/Phi impractical at this time. Unless you have a use case identified for either the GPU/Phi, you may be better off putting that money towards upgrade of some other components.
        If you have some application that make use of floating point calculations a lot, then the value of GPU will show. For example, I have a CUDA program that calculates pairwise familial relationships between my samples.

        Another way of thinking is that using GPU can make your system more compact. For example, you can run soap3-dp on a GPU and then do other stuff with your CPUs. In this sense, your computations per one computer case volume will be higher than without GPU.

        Comment


        • #5
          I missed the most recent discussion, thanks for the link, very useful. Also thanks a lot for other useful inputs.

          Comment

          Latest Articles

          Collapse

          • seqadmin
            Current Approaches to Protein Sequencing
            by seqadmin


            Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
            04-04-2024, 04:25 PM
          • seqadmin
            Strategies for Sequencing Challenging Samples
            by seqadmin


            Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...
            03-22-2024, 06:39 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by seqadmin, 04-11-2024, 12:08 PM
          0 responses
          24 views
          0 likes
          Last Post seqadmin  
          Started by seqadmin, 04-10-2024, 10:19 PM
          0 responses
          25 views
          0 likes
          Last Post seqadmin  
          Started by seqadmin, 04-10-2024, 09:21 AM
          0 responses
          21 views
          0 likes
          Last Post seqadmin  
          Started by seqadmin, 04-04-2024, 09:00 AM
          0 responses
          52 views
          0 likes
          Last Post seqadmin  
          Working...
          X